ArticleScientific reports2025
Efficient deep neural networks for cancer detection on histopathology combining attention and image downsampling.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Pathology diagnosis of colorectal cancer is time-consuming and requires a high level of expertise. However, it is an essential step towards establishing the adequate treatment. The need to analyse a large number of these histopathological images calls for automatic tools capable of aiding pathologists in this arduous task. Deep learning techniques, together with the wealth of data available nowadays, provide a promising candidate for such job. Adopting state-of-the-art artificial intelligence algorithms, we developed a model to accurately detect colorectal cancer in digitalised histopathological whole-slide images. Our end-to-end approach uses the principles of multiple-instance learning combined with deep convolutional neural networks in order to fully leverage the information contained within each image and make robust predictions at the patient's level. The model also allows to highlight the areas in the slide most likely to harbour tumour tissue. Given the finite computational resources available, working at maximum resolution can be detrimental. Therefore, we explored the impact of lowering the working image resolution. The algorithms were trained and validated on a subset of more than 1300 patients of the Molecular Epidemiology of Colorectal Cancer study with histopathology images available. These images gave rise to [Formula: see text] tiles of [Formula: see text] pixels each. Once we identified the best-performing model we put it to the test on images from The Cancer Genome Atlas. We obtained the best outcomes working at 4 μm/pix, achieving the following metrics on the test dataset: F1-Score of 0.96, a Matthews correlation coefficient of 0.92 and an area under the receiver operating characteristic curve of 0.99. These results are exceptional and prove that computational costs can be reduced while keeping the performance up to standard.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.